Nearly 4 million Americans received updated COVID boosters last week - CDC | Inquirer News

Nearly 4 million Americans received updated COVID boosters last week – CDC

/ 11:31 AM October 07, 2022

People receive COVID-19 boosters targeting Omicron

Colleen Dempsey, 54, receives the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants at Skippack Pharmacy in Schwenksville, Pennsylvania, US, September 8, 2022. REUTERS/Hannah Beier/File Photo

Around 3.9 million people in the United States received updated COVID-19 booster shots over the past week, the Centers for Disease Control and Prevention said on Thursday.

The CDC said a total of 11.5 million Americans had received the shot as of October 5, the first five weeks the booster has been available. This is up from the 7.6 million people who received the shot as of September 28.

Article continues after this advertisement

The 11.5 million figure represents only 5.3% of the 215.5 million people in the United States aged 12 or older who are eligible to receive the shots because they have completed their primary vaccination series.

FEATURED STORIES

The shots are being administered at a slower pace than last year, when the United States initially authorized COVID boosters just for older and immunocompromised people. Around 20 million people received their third shot in the first five weeks of that vaccination campaign.

A recent survey conducted by the nonprofit Kaiser Family Foundation found that nearly two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon.

Article continues after this advertisement

The US Food and Drug Administration authorized Pfizer and Moderna’s Omicron-tailored shots in August in preparation for the country’s ongoing fall revaccination campaign.

Article continues after this advertisement

The CDC tally includes booster shots from both Pfizer/BioNtech and Moderna.

Article continues after this advertisement

While the Pfizer/BioNTech updated COVID-19 booster is approved for those aged 12 and above, Moderna’s shot is approved for individuals aged 18 and above.

These Omicron-tailored shots aim to tackle the BA.5 subvariants, which makes up a significant majority of the currently circulating variants in the United States, according to government data. These shots are expected to also be effective against the slowly rising BA.4.6 subvariant.

RELATED STORIES:

What to know about ‘bivalent vaccines’ that target Omicron

DOH clings to boosters as severe COVID among vaccinated rises

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: boosters, CDC, COVID-19, United States, world news

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.